Utah Governor and BioUtah Recognize Co-Diagnostics Following Saudi Arabia Joint Venture

By Advos

TL;DR

Co-Diagnostics gains strategic advantage by establishing CoMira Diagnostics joint venture in Saudi Arabia, expanding its patented PCR platform across Middle East and North Africa markets.

Co-Diagnostics forms CoMira Diagnostics through a definitive joint venture agreement with Arabian Eagle to localize manufacturing and distribution of its molecular diagnostic tests in Saudi Arabia.

Co-Diagnostics' expansion into Middle Eastern markets through CoMira Diagnostics will improve global healthcare access by providing advanced diagnostic tools to more patients worldwide.

A Utah-born diagnostics company recognized by Governor Cox is now competing globally through a Saudi joint venture that localizes PCR technology across the Middle East.

Found this article helpful?

Share it with your network and spread the knowledge!

Utah Governor and BioUtah Recognize Co-Diagnostics Following Saudi Arabia Joint Venture

Utah Governor Spencer Cox and BioUtah President Kelvyn Cullimore have formally recognized Co-Diagnostics, Inc. following the company's announcement of a significant joint venture in the Kingdom of Saudi Arabia. The recognition highlights the growing international presence of Utah-based life sciences companies and their expanding global impact in the healthcare diagnostics sector.

Governor Cox emphasized the broader implications of this expansion, stating that Co-Diagnostics represents Utah-born companies competing internationally. The governor noted that the company's expansion across the Middle East and North Africa regions reflects the strength of Utah's life sciences sector and the determination of local entrepreneurs. This international growth demonstrates how regional companies can develop tools that benefit patients worldwide while showcasing Utah's economic development capabilities.

Kelvyn Cullimore of BioUtah, the state's life sciences trade association, highlighted the significance of the joint venture agreement with the Saudi company. Cullimore confirmed that the definitive JV agreement further establishes Co-Diagnostics' expanding leadership position in the global diagnostics market. The recognition from both state government and industry leadership underscores how such international partnerships validate Utah's life sciences community, which ranks among the fastest-growing in the United States.

The joint venture, named CoMira Diagnostics, represents a strategic expansion for Co-Diagnostics, which develops advanced molecular diagnostic tests using its patented technology platform. The company's technologies are utilized for tests designed to detect and analyze nucleic acid molecules, including DNA and RNA. This expansion into Saudi Arabia comes as the company also develops its Co-Dx PCR at-home and point-of-care platform, though this platform remains subject to regulatory review and is not currently available for sale.

The recognition event and the underlying joint venture announcement highlight several important trends in global healthcare and economic development. First, it demonstrates how regional companies can successfully expand into international markets, particularly in regions with growing healthcare infrastructure like the Middle East and North Africa. Second, it showcases Utah's emerging position as a hub for life sciences innovation, with companies developing technologies that address global health challenges.

For the diagnostics industry, this expansion represents continued globalization of molecular testing technologies and the growing demand for advanced diagnostic solutions in emerging markets. The partnership also signals potential for increased technology transfer and collaboration between United States and Middle Eastern healthcare companies, potentially leading to improved diagnostic capabilities and healthcare outcomes in the region.

The original announcement was republished with permission from the Co-Diagnostics November 12, 2025, press release. The recognition from both state government and industry leadership positions this development as significant not only for the company but for Utah's broader economic and innovation ecosystem.

Curated from Reportable

blockchain registration record for this content
Advos

Advos

@advos